Physician profile
Matthew Parisi
NPI 1801270095
$734.50
in general payments reported to CMS, 2019-2025
14 companies · $93.59 in 2025
The $93.59 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.38 · 2020: $53.23 · 2021: $84.35 · 2022: $128 · 2023: $210 · 2024: $146 · 2025: $93.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $139.52 | 2023-2024 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $127.37 | 2022-2025 | Orthovisc, Monovisc |
| Vertex Pharmaceuticals Incorporated | $94.78 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $91.71 | 2020-2023 | |
| Fidia Pharma USA INC. | $70.25 | 2021-2023 | Hymovis, Triluron |
| Zimmer Biomet Holdings, INC. | $55.99 | 2023-2024 | Gel-One Cross-Linked Hyaluronate |
| Ferring Pharmaceuticals INC. | $38.98 | 2020-2021 | |
| Bioventus LLC | $22.77 | 2022 | |
| Boston Scientific Corporation | $19.38 | 2019 | |
| Exact Sciences Corporation | $18.66 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $16.97 | 2022 | |
| Assertio Therapeutics, INC. | $13.66 | 2020 | |
| Horizon Therapeutics Plc | $13.33 | 2021 | |
| Zyla Life Sciences, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Parisi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.